Department of Hematology and Oncology, Children's Hospital of Richmond at VCU, Richmond, VA.
J Pediatr Hematol Oncol. 2023 Apr 1;45(3):159-161. doi: 10.1097/MPH.0000000000002616. Epub 2023 Jan 9.
Diamond-Blackfan anemia (DBA) is a rare congenital bone marrow failure syndrome, with a hallmark of erythroblastopenia and congenital anomalies. DBA demonstrates genetic heterogeneity and variable phenotypic expression. We present two cases of atypical DBA harboring de novo mutations in the RPS-19 gene with c.49 G>C and c.357-1G>T allelic variants. The two cases presented confounding critical illness demonstrated by multiorgan failure, aplastic crisis, with case 2 meeting the criteria for hemophagocytic lymphohistiocytosis. We highlight the utility of genetic testing in the early diagnosis of DBA and the associated complexities and burden of disease in caring for DBA patients.
先天性红细胞生成性卟啉病(DBA)是一种罕见的先天性骨髓衰竭综合征,其特征为红系前体细胞减少和先天性异常。DBA 表现出遗传异质性和不同的表型表达。我们报告了两例携带 RPS-19 基因新发突变的非典型 DBA 病例,突变类型分别为 c.49G>C 和 c.357-1G>T 等位基因变异。这两例病例表现为多器官衰竭、再生障碍危象等并发症,具有严重的疾病状态,其中病例 2 符合噬血细胞性淋巴组织细胞增生症的诊断标准。我们强调了基因检测在 DBA 早期诊断中的作用,以及在治疗 DBA 患者时疾病的复杂性和负担。